Export

EN
FR
Cycloserine
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.5. Antituberculosis medicines
ATC codes: J04AB01
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis ICD11 code: ML32.00
INN
Cycloserine
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Additional notes
The square box applies only to listing of cycloserine on the EML.
Formulations
Oral > Solid > dosage form: 250 mg ; 125 mg (EMLc)
EML status history
First added in 1999 (TRS 895)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 950)
Changed in 2015 (TRS 994)
Changed in 2019 (TRS 1021)
Changed in 2021 (TRS 1035)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
terizidone (ATC codes: J04AK03)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Cycloserine
DrugBank
Cycloserine
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the transfer of listings for medicines for multi-drug resistant tuberculosis from the complementary to the core list of the EML and EMLc.